Journal of Neuroinflammation (Jul 2010)

Gp91<sup>phox </sup>(NOX2) in classically activated microglia exacerbates traumatic brain injury

  • Tsunawaki Shohko,
  • Song Dandan,
  • Miyamoto Kazuyuki,
  • Satoh Kazue,
  • Yofu Sachiko,
  • Nakamachi Tomoya,
  • Ohtaki Hirokazu,
  • Dohi Kenji,
  • Shioda Seiji,
  • Aruga Tohru

DOI
https://doi.org/10.1186/1742-2094-7-41
Journal volume & issue
Vol. 7, no. 1
p. 41

Abstract

Read online

Abstract Background We hypothesized that gp91phox (NOX2), a subunit of NADPH oxidase, generates superoxide anion (O2-) and has a major causative role in traumatic brain injury (TBI). To evaluate the functional role of gp91phox and reactive oxygen species (ROS) on TBI, we carried out controlled cortical impact in gp91phox knockout mice (gp91phox-/-). We also used a microglial cell line to determine the activated cell phenotype that contributes to gp91phox generation. Methods Unilateral TBI was induced in gp91phox-/- and wild-type (Wt) mice (C57/B6J) (25-30 g). The expression and roles of gp91phox after TBI were investigated using immunoblotting and staining techniques. Levels of O2- and peroxynitrite were determined in situ in the mouse brain. The activated phenotype in microglia that expressed gp91phox was determined in a microglial cell line, BV-2, in the presence of IFNγ or IL-4. Results Gp91phox expression increased mainly in amoeboid-shaped microglial cells of the ipsilateral hemisphere of Wt mice after TBI. The contusion area, number of TUNEL-positive cells, and amount of O2- and peroxynitrite metabolites produced were less in gp91phox-/- mice than in Wt. In the presence of IFNγ, BV-2 cells had increased inducible nitric oxide synthase and nitric oxide levels, consistent with a classical activated phenotype, and drastically increased expression of gp91phox. Conclusions Classical activated microglia promote ROS formation through gp91phox and have an important role in brain damage following TBI. Modulating gp91phox and gp91phox -derived ROS may provide a new therapeutic strategy in combating post-traumatic brain injury.